Evaluate the importance of integrating pharmacogenomic considerations into global drug development strategies.

Question

BlackTom AI · Accepted Answer

Question restatement: The prompt asks about the importance of including pharmacogenomic considerations in global drug development strategies.
Option 1: 'It complicates drug development processes without providing significant benefits.' This view is overly pessimistic. While incorporating pharmacogenomics may add complexity, it can yield meaningful benefits by predicting who will respond well, who may suffer adverse effects, and how dosing might be optimized, which can ultimately improve safety and efficacy.
Option 2: 'Integrating pharmacogenomic considerations can lead to more globally effective and safer drugs by accounting for genetic diversity.' This is the strongest claim. Genetic diversity across populations influences drug metabolism, efficacy, and risk of adverse reactions. A global development strategy that accounts for these differences can tailor therapies to subgroups, reduce trial failures due to population differences, and support regulatory approval across regions with more robust, diverse data.
Option 3: 'Global strategies should focus on economic factors, not genetic variations.' Although economic considerations are important, dismissing genetic variation ignores a key driver of differential drug response. Economic planning does not replace pharmacogenomic insights; both aspects are relevant to successful global development.
Option 4: 'It is unnecessary as genetic factors are consistent globally.' This statement is inaccurate. Genetic variation exists among populations due to ancestry, allele frequencies, and environment, leading to different pharmacokinetic and pharmacodynamic profiles. Therefore, assuming uniform genetics across the globe is incorrect and could risk safety and efficacy.
In summary, option 2 aligns with the evidence that pharmacogenomics enhances global drug development by acknowledging genetic diversity and tailoring therapies accordingly, while options 1, 3, and 4 either overlook the benefits or rely on incorrect assumptions about genetics and global applicability.

PCOL2021 2025 Module 3 Quiz

Evaluate the importance of integrating pharmacogenomic considerations into global drug development strategies.

View Explanation

Log in for full answers

Similar Questions

Evaluate the implications of pharmacogenomic variations in metabolizing enzymes when designing a clinical trial for a new cardiovascular drug.

How can genetic variation in HLA antigens influence drug therapy outcomes?

When considering the variability of drug metabolism among different geographical ancestries, which factor is most relevant for optimizing patient-specific therapy?

In evaluating a patient’s CYP2D6 phenotype before prescribing a drug with a narrow therapeutic window, which of the following represents the most critical clinical concerns?

Which factor is NOT typically influenced by genetic variations in pharmacogenomics?

What role do drug transporters play in pharmacogenomics?

In a consumer society, many adults channel creativity into buying things

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler